The FDA adds a new boxed warning for immune effector cell-associated enterocolitis with Carvykti, but says the overall ...
MedPage Today on MSN
CAR-T Drug for Myeloma Hit With New Boxed Warning
Ciltacabtagene autoleucel (cilta-cel; Carvykti) for multiple myeloma has a new boxed warning for immune effector ...
The U.S. Food and Drug Administration approved on Friday labeling changes for the blood cancer therapy of Johnson & Johnson ...
FDA updates Johnson & Johnson's Carvykti label to warn of rare immune-related enterocolitis while reaffirming the therapy's ...
The U.S. Food and Drug Administration (FDA) has updated the safety labeling for Carvykti, the multiple myeloma therapy ...
Food and Drug Administration on Friday approved labeling changes for Johnson & Johnson and its partner Legend Biotech's blood ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback